Share from 0:00
0:00
/
0:00
Transcript
Zurich based CUTISS is developing a personalized tissue therapy that enables on-demand production of living skin for surgeries
Co-Founder & CEO Daniela Marino describes why CUTISS believes denovoSKIN is superior to autografting.
BiotechTV
Authors
BiotechTV
Recent Posts
Share this post